A broadly neutralizing germline-like human monoclonal antibody against dengue virus envelope domain III-Reference-Cited by-同舟云学术

A broadly neutralizing germline-like human monoclonal antibody against dengue virus envelope domain III

Published:2019-06-26 Issue:6 Volume:15 Page:e1007836
ISSN:1553-7374
Container-title:PLOS Pathogens
language:en
Short-container-title:PLoS Pathog

Author:

Hu Dan,Zhu Zhongyu,Li Shun^ORCID,Deng Yongqiang,Wu Yanling,Zhang Nana,Puri Vinita^ORCID,Wang Chunyu,Zou Peng,Lei Cheng,Tian Xiaolong,Wang Yulu,Zhao Qi^ORCID,Li Wei,Prabakaran Ponraj,Feng Yang,Cardosa Jane,Qin Chengfeng,Zhou Xiaohui^ORCID,Dimitrov Dimiter S.,Ying Tianlei^ORCID

Publisher

Public Library of Science (PLoS)

Subject

Virology,Genetics,Molecular Biology,Immunology,Microbiology,Parasitology

Reference70 articles.

1. The WHO dengue classification and case definitions: time for a reassessment;JL Deen;Lancet,2006

2. Global spread and persistence of dengue;JL Kyle;Annu Rev Microbiol,2008

3. The risks behind Dengvaxia recommendation;M Aguiar;The Lancet Infectious Diseases,2016

4. Dengvaxia: age as surrogate for serostatus;M Aguiar;The Lancet Infectious Diseases,2018

5. Dengvaxia controversy: impact on vaccine hesitancy;K Fatima;J Glob Health,2018

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Engineered N-Glycosylated Dengue Envelope Protein Domain III Facilitates Epitope-Directed Selection of Potently Neutralizing and Minimally Enhancing Antibodies;ACS Infectious Diseases;2024-06-29

2. Screening of bio-recognition elements by phage display and their application in the detection of foodborne pathogens;TrAC Trends in Analytical Chemistry;2024-02

3. Dengue virus neutralizing antibody: a review of targets, cross-reactivity, and antibody-dependent enhancement;Frontiers in Immunology;2023-06-02

4. Isolation and Genetic Evolution of Dengue Virus from the 2019 Outbreak in Xishuangbanna, Yunnan Province, China;Vector-Borne and Zoonotic Diseases;2023-06-01

5. Monoclonal antibody therapeutics for infectious diseases: Beyond normal human immunoglobulin;Pharmacology & Therapeutics;2022-12